Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
North America is Expected to Dominate the "Global Drug Delivery Devices Market – Trends and Forecast to 2022" a New Report by Data Bridge Market Research
Global Drug Delivery Devices Market Trends and Forecast to 2022 - By Route of Administration (Oral, Injectable, Topical, Pulmonary, Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Ambulatory Surgery Centers/Clinics, Home Care Settings, Diagnostic Centers, Others), By Geography (North America, Europe, Asia-Pacific, Rest of the World) - May 04, 2016 - Data Bridge Market Research
Sentynl Therapeutics, Inc. Acquires Abstral®
Sentynl Therapeutics, Inc. (“Sentynl”) announced that it acquired the rights to market Abstral® in the U.S. from Galena Biopharma. Abstral® is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentnyl Therapeutics, Inc. Re-Launches Abstral® in the United States
Sentynl Therapeutics, Inc. (“Sentynl”) announced that its commercial organization relaunched Abstral® in the United States. Sentynl acquired the rights to market Abstral® from Galena Biopharma in November 2015. Abstral® is indicated for the management of breakthrough pain... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Launches Sentynl Patient Services
Sentynl Therapeutics, Inc. (“Sentynl”) announced that it launched Sentynl Patient Services to enhance patient access to its products. Sentynl Patient Services provides support to patients who want assistance with investigating their benefits, affording their medications and locating... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Launches Its Commercial Organization
Sentynl Therapeutics, Inc. (“Sentynl”) announced that it launched its commercial organization including a full-time, professional sales force of key account specialists. About Sentynl Therapeutics. Sentynl provides healthcare professionals with treatment solutions that enable them to... - April 30, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Welcomes Michael Hercz as Its Senior Vice President and General Counsel
Sentynl Therapeutics, Inc. (“Sentynl”) announced that Michael Hercz joined Sentynl as its Senior Vice President, General Counsel and Chief Compliance Officer. Mr. Hercz brings more than 18 years of legal, compliance and risk management experience to Sentynl. Prior to Sentynl, Mr. Hercz... - April 30, 2016 - Sentynl Therapeutics, Inc.
The Importance of in Vitro Discussed at ADMET 2016
SMi reports: The importance of in vitro is just one of the key topics to be discussed at SMi’s 11th annual ADMET conference which will return to London on the 13th-14th June 2016. - April 29, 2016 - SAE Media Group
Abzena, Bachem, Ipsen, IRBM, MedImmune and Sanofi to Explore Industry Innovations in July
SMi Group reports: 3rd Peptides Conference in July to feature topics on the latest innovations in pre-clinical development to facilitate the advancement of next generation peptides. - April 29, 2016 - SAE Media Group
IDC MarketScape Names Acsis a Major Player in the Pharmaceutical Track and Trace Software Market
Acsis, a leading provider of supply chain serialization solutions, today announced that leading IT market research and advisory firm IDC has named it a “Major Player” in the IDC MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 Vendor Assessment (doc # US40511116,... - April 29, 2016 - Acsis Inc.
Latin America Medical Cannabis Conference in Costa Rica on July 27-29th
The purpose of this conference is to provide education on the subject of the fast-growing Medical Cannabis Industry, and provide first-hand stories from people who have been helping patients using Medical Cannabis. In Latin American, Colombia and Uruguay have already passed Medical Cannabis legislation and Costa Rica; Chile, Peru, Mexico and Argentina have bills in the works. - April 28, 2016 - Costa Rican Medical Care
Compounding Pharmacy Supplies Medication for Study Using Edetate Disodium Therapy
Following the generally positive outcome of the National Institutes of Health-funded Trial to Assess Chelation Therapy (TACT)[1] study completed in 2012, it was decided that further research was warranted to test the safety and effectiveness of Chelation therapy as a treatment option for... - April 27, 2016 - Universal Arts Compounding Pharmacy
MHRA Exclusive: Spotlight on Effective Biobanking Operations and Regulatory Compliance
SMi’s 6th Biobanking conference returns to London on 20th – 21st June at the Holiday Inn Kensington Forum. - April 23, 2016 - SAE Media Group
San Diego Intellectual Property Management and Consulting Firm Established by Seasoned Patent Agent
WALLACH IP Management and Consulting announced a new business venture focused on professional patent protection services. Founder Dr. Brenda Wallach, who has nearly twenty years' experience advising cutting-edge companies, is filling a critical need for companies that must protect their intellectual property and do so at a reasonable cost. The firm specializes in the areas of biotechnology, pharmaceuticals, therapeutics, renewable biofuels and medical devices. - April 21, 2016 - WALLACH IP Management and Consulting
10th Clinical Trial Logistics Event to Feature Guidance on Maximising Supply Chain Strategy
SMi Group reports (18.04.2016) – Presentations from Karyopharm Therapeutics, Norgine and Sanofi give guidance for supply chain efficacy. - April 20, 2016 - SAE Media Group
Global Pharmaceutical Excipient Market Worth US$ 7,415.2 Mn by 2021 : PMR
The growth of the global pharmaceutical excipients market is mainly driven by increasing demand for drugs that can be consumed orally. Ease of consumption and associated patient comfort has been pushing big drug makers to develop sustained-release dosage formulations. - April 20, 2016 - Persistence Market Research
LAMEA Oncology/Anti-Cancer Drugs Market is Expected to Reach $17.0 Billion, by 2021
A new report published by Allied Market Research titled, LAMEA Oncology/Anti-Cancer Drugs Market - Opportunities and Forecasts, 2014-2021," projects that the LAMEA oncology/cancer drugs market would reach $17.0 billion by 2021, registering a CAGR of 8.6% from 2015 to 2021. Chemotherapy segment... - April 17, 2016 - Allied Market Research
World Excipients Market is Expected to Reach $6.4 Billion by 2020
A new report published by Allied Market Research titled, “World Excipients Market—Opportunities and Forecasts, 2014–2020,” projects that the world excipients market would reach $6.4 billion by 2020 at a CAGR of 7.6% during 2015 and 2020. Organic chemicals would continue to... - April 17, 2016 - Allied Market Research
Myrta A. See Recognized as a Professional of the Year by Strathmore's Who's Who Worldwide Publication
Myrta A. See of Broadway, Virginia has been recognized as a Professional of the Year for 2016 by Strathmore’s Who’s Who Worldwide for her outstanding contributions and achievements in the field of pharmaceuticals. About Myrta A. See Ms. See has over 3 years experience in the... - April 16, 2016 - Strathmore Worldwide
MedImmune Explores a Therapeutic Lead for Treatment of Type 2 Diabetes and Obesity
SMI Reports (13.04.2016): MedImmune Senior Director for R&D to present keynote address on MED10382. - April 15, 2016 - SAE Media Group
New Speakers from MHRA and FedEx Announced for the 10th Clinical Trial Logistics Event in May
SMi reports: MHRA and FedEx to speak at SMi Group’s Clinical Trial Logistics event in London on 18-19 May. - April 14, 2016 - SAE Media Group
SMi’s Parallel Trade - Management Strategies Masterclass 2016 Now Open for Registration
SMi Group reports: Registration is now live for the exclusive masterclass "Parallel Trade – Management Strategies" which takes places on the 14th July 2016 in London, UK. - April 14, 2016 - SAE Media Group
GSK and Lundbeck Present on Improving Drug-Drug Interaction at ADMET 2016
SMi reports: SMi’s 11th annual conference and exhibition on ADMET will return to London on the 13th-14th June 2016. - April 13, 2016 - SAE Media Group
Virun® at Ingredient Marketplace, Patent Grant in S. Korea, New Product Launches, Debut of Lightbulb Virun T-Shirts, and Webinar Controversy
VIRUN® plans on taking Orlando by storm at Ingredient Marketplace, where Virun’s Esolv® technology will take center stage, and Virun’s unique Omega smoothies and beverages will be available for sampling. South Korea granted Virun yet another patent protecting its unique technology. Virun launches new products and a new t-shirt. Virun’s latest webinar, “Inside Virun,” sparks controversy, and provides new business opportunities. - April 12, 2016 - VIRUN
Attendee List Released for SMi's 13th Annual Controlled Release Conference
SMi's 13th annual Controlled Release conference, taking place on 18th - 19th April 2016 in London, UK, will feature case studies from leading regulatory bodies and an array of major global pharmaceutical companies. - April 09, 2016 - SAE Media Group
Patent Issued for Stable Vitamin C Formulation
Dr. Andrew Chadeayne has been issued a patent for a stable form of vitamin C - which does not breakdown in liquid solution. While vitamin C is useful anywhere that oxidation is a problem, it breaks down rapidly. According to the inventor, Dr. Chadeayne, “This is the first stable solution of... - April 06, 2016 - SwimSpray
Blazers VS Nugs Portland Trailblazers Take on the Denver Nuggets for the Blazers Last Home Game of the Season
The Seattle SuperChronic Cafe Presents "Blazers VS Nugs" private suite (sky-box) at the Moda Center with retired Trailblazer Cliff Robinson, aka Uncle Spliffy Wednesday April 13th. This event at the Blazers VS Nuggets NBA game is an opportunity to normalize cannabis in a professional setting, while promoting an Active Cannabis Lifestyle. More on FB @SuperChronic_Cafe - April 05, 2016 - SuperChronic Cafe
Florian M. Ward, Ph.D. Recognized as a VIP for 2016 by Strathmore's Who's Who Worldwide Publication
Florian M. Ward, Ph.D. of Bel Air, Maryland has been recognized as a VIP for 2016 by Strathmore’s Who’s Who Worldwide Edition for her outstanding contributions and achievements in the fields of consulting and inventing. About Florian M. Ward, Ph.D. Dr. Ward has over 20 years experience... - April 05, 2016 - Strathmore Worldwide
SMi’s 3rd Peptides Conference to Feature a Live Learning Lab on Peptide Development and Manufacturing
Registration is now live for SMi Group's 3rd Peptides Conference which takes place in London on 6th - 7th July at the Holiday Inn Kensington Forum. - April 04, 2016 - SAE Media Group
MHRA and US FDA to Discuss Innovation in Controlled Release
SMi's 13th annual Controlled Release conference, taking place on 18th - 19th April 2016 in London, will feature case studies from leading regulatory bodies and an array of major global pharmaceutical companies. - March 31, 2016 - SAE Media Group
SAPA Successfully Organized Workshop on Regulatory Affairs of Botanical and Chinese Medicines
SAPA organized a workshop at DoubleTree Conference Center located in Somerset, NJ. With the generous support of Shimadzu China Corporation, SAPA invited several prominent speakers to present at this workshop: Mr. Hongyu Jin from China Food and Drug Administration (CFDA), Dr. Jinhui Dou from US Food and Drug Administration (FDA), and Mr. Andrew Jiang - CEO of Aleon Pharma International. The workshop was hosted by regulatory affairs expert Dr. Xin Du and attracted nearly 100 attendees. - March 29, 2016 - Sino-American Pharmaceutical Professionals Association
Global Medical Solutions to Sell China Operations to Yantai Dongcheng Biochemicals
Global Medical Solutions to sell China Operations to Yantai Dongcheng Biochemicals and enter into a long-term collaborative partnership in China. - March 28, 2016 - Global Medical Solutions
AXSource Global Launches an Enhanced ERP Solution for Life Sciences Companies
AXOQCS™ is complete business solution developed for Microsoft Dynamics AX that provides quality and compliance functionality. Pharmaceutical and Medical Devices manufacturers need a solution that is flexible, responsive, and integrated. AXOQCS™ is a unique ERP solution for Pharma and Life Sciences manufacturers that streamlines and integrates quality and compliance processes, helping them comply with FDA Good Manufacturing Practices while maintaining efficiency and profitability across business. - March 26, 2016 - AxSource
New Bioreactor Tubing Kits from AdvantaPure(R) Speed Turnaround and Increase Processing Capacity; Single-Use and Customizable for Benchtop Bioreactors
Custom, Single-Use Bioreactor Tubing Kits, new from AdvantaPure, contain tubing, filters and connectors for harvest, vent, sparge and addition lines used in benchtop bioreactors. Because the kits arrive preassembled, they provide quicker turnaround time, convenience and less chance of cross contamination. Platinum-cured silicone or AdvantaFlex(R) TPE tubing may be selected as the tubing components in each kit. This product will be exhibited at Interphex booth 3055. - March 24, 2016 - AdvantaPure
Global Pharmaceutical Excipient Market to Grow US$ 7,415.2 Mn by 2021: Persistence Market Research
The global pharmaceutical excipients market is estimated to be valued at US$ 7,415.2 Mn by 2021 end, with various markets registering significant CAGRs during the forecast period. - March 23, 2016 - Persistence Market Research
Best Health Care Website to be Named by Web Marketing Association in 20th Annual WebAward Competition
The best healthcare websites in the world will be named as part of the Web Marketing Association's 20th annual international WebAward Competition for Web site development at www.webaward.org. The WebAwards is the standards-defining competition that sets benchmarks for 96 industries, including healthcare, healthcare provider, medical, medical equipment, biotechnology and pharmaceutical websites, based on the seven criteria of a successful web site. - March 18, 2016 - Web Marketing Association
Sanofi-Aventis and Roche Discuss Linking PK with Safety at ADMET 2016
SMi are delighted to have Sanofi-Aventis and Roche amongst the speaker line-up for the 11th annual ADMET conference and exhibition which takes place on the 13th-14th June 2016, London, UK. - March 15, 2016 - SAE Media Group
Biogen, Teva, Medimmune, Pfizer, Shire to Share Insights and Project Updates at Pre-Filled Syringes West Coast 2016
SMi Group Reports (2016.03. 08, San Diego, California, USA): Registration is now open to attend Pre-Filled Syringes West Coast 2016 in San Diego. - March 12, 2016 - SAE Media Group
A Tale of Two New Hepatitis C Drugs
Despite discount, Merck’s just approved Zepatier unlikely to win share with most US payers, except in Medicaid, according to RxScorecard™. New combo from Gilead could ensure company’s dominant position among US payers. - March 11, 2016 - Real Endpoints
Earn CPD Points as You Prepare Yourself for New Compliance Guidelines
SMi Training's CPD accredited masterclass: “Compliance with the New Regulations for Medical Devices and In Vitro Diagnostic Products” will take place on the 4th April in London, UK. - March 11, 2016 - SAE Media Group
Reducing Risk with Containment of Highly Potent API’s Addressed Later This Month
SMi Training's CPD accredited masterclass: “Containment of Highly Potent API’s” will take place on the 22nd March 2016 in London, UK. - March 11, 2016 - SAE Media Group
The 2016 SAPA Career Forum Discussions with Young Professionals
On February 27, 2016, Sino-American Pharmaceutical Professionals Association (SAPA) hosted a career forum with young professionals at Rutgers University. This forum is co-organized by the Rutgers University iJOBS program, Rutgers Chinese Students and Scholars Association, Association of Chinese... - March 10, 2016 - Sino-American Pharmaceutical Professionals Association
Addressing the Challenges in Biomanufacturing
The life sciences industry is evolving on a global scale. Shifting market demands, health care reforms and more stringent regulations are presenting new challenges to the industry at large. Taking a holistic approach to the challenges and opportunities that biomanufacturers face, Generis' American Biomanufacaturing Summit 2016 will present attendees with first-hand case studies, strategies and best practices to advance manufacturing excellence, drive innovation and develop the necessary leaders. - March 10, 2016 - Generis Group
New Podcast “How Organizations are Navigating Risk Based Approaches in Clinical Trials” Now Available on WorldCongress.com
UCB Biosciences, Inc.’s Director/Head, Risk Based Monitoring, Justin, Stark, addresses centralized monitoring and on-site monitoring and how organizations are navigating risk based approaches in a new podcast available on the World Congress website. The podcast is geared toward those involved in clinical trial design, operations and risk management. - March 09, 2016 - World Congress
Makers Nutrition Launches Premium Stock Formulas
Fast-Growing Nutraceutical Company Offers Nine Popular Stock Formulas to Vitamin and Supplement Businesses - March 08, 2016 - Makers Nutrition, LLC
Versaic Launches Solution to Streamline Medical Affairs for Pharmaceuticals
New solution integrates easy to use interface, fully customizable process, time-saving reporting features, and ongoing support from dedicated client success managers. - March 03, 2016 - Versaic
Biobanking Conference to Tackle Regulatory Updates and Impacts on Industry
SMi Group reports (2016.29.02 – London, UK): Registration is now live for the 6th annual Biobanking Conference and Exhibition on 20-21 June at the Holiday Inn Kensington Forum, London, UK. - March 02, 2016 - SAE Media Group
Ixogel®: Agreement on Special Protocol Assessment (SPA) by the US Food and Drug Administration for the Prevention of Lyme Disease
Ixodes AG, a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention of Lyme Disease, today announced that the company has reached agreement with the US Food and Drug Administration (FDA) on the phase III protocol according to the Special Protocol... - March 01, 2016 - Ixodes AG
AgmaSet for Nerve Health Launched in the Philippines
Gilad&Gilad, the exclusive manufacturer and supplier of AgmaSet®, a unique supplements for nerve health, is collaborating with JCS Pharmaceuticals Inc. for distribution in the Philippines According to Dr. Gad M. Gilad, CEO of Gilad&Gilad, "The Philippines Ministry of Health has... - March 01, 2016 - Gilad&Gilad
Recursion Pharmaceuticals Supports White House Precision Medicine Initiative
Recursion Pharmaceuticals today announced that it is part of a group of nationally recognized private and public institutions making commitments as part of President Obama's Precision Medicine Initiative to rapidly find new treatments for ultra-rare genetic diseases. - February 25, 2016 - Recursion Pharmaceuticals
Makers Nutrition Hires Stephen Finnegan as General Manager
Rapidly growing nutraceutical company turns to seasoned executive to help lead expansion. - February 25, 2016 - Makers Nutrition, LLC